A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to see how molecules called pharmacological chaperones affect the cells of patients with Pompe disease. The study will last 1 or 2 visits which will include a blood collection, urine collection, and two skin biopsies. Information will also be collected from the medical records about disease history and diagnosis. Patients will not receive any study medication.
Full description
The study is designed to evaluate the response of cell lines derived from blood and skin tissue from Pompe patients to pharmacological chaperones. Samples of blood and skin tissue will be obtained to make cell lines that will be used to test pharmacological chaperones. The study will include patients with early and late-onset Pompe disease.
Enrollment
Sex
Volunteers
Inclusion criteria
- Male or female of any age
- Confirmed diagnosis of Pompe disease (early or late-onset)
- Clinically stable
- Written informed consent by subject or legal representative
Exclusion criteria
- Other significant disease or otherwise unsuitable for the study, as determined by the investigator
Trial design
30 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal